Avita Therapeutics, Inc. (RCEL) has 40 open-market insider trades by 9 insiders since 2020. Over the last six months insiders net bought $206K. The most active filer is David D. O'Toole, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Michael S. Perry | Dir | — | 6 | $5.8M | 2022-11-21 |
| Robert McNamara | Dir | — | 4 | $379K | 2026-01-20 |
| David D. O'Toole | CFO | — | 19 | $348K | 2026-06-12 |
| Joseph Fralin Woody | Dir | — | 4 | $189K | 2026-06-09 |
| Donna Shiroma | CLO | — | 1 | $133K | 2024-05-31 |
| Jeremy Curnock Cook | Dir | — | 2 | $62K | 2026-01-20 |
| Suzanne Crowe | Dir | — | 2 | $25K | 2026-01-20 |
| James Corbett | CEO | — | 1 | $19K | 2023-12-26 |
| David McIntyre | CFO | — | 1 | $16K | 2020-07-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Joseph Fralin Woody | Director | Buy | $21K | 2026-06-09 |
| Joseph Fralin Woody | Director | Buy | $42K | 2026-06-09 |
| Joseph Fralin Woody | Director | Buy | $41K | 2026-06-03 |
| Joseph Fralin Woody | Director | Buy | $85K | 2026-06-01 |
| David D. O'Toole | CFO | Buy | $9K | 2026-05-20 |
| David D. O'Toole | CFO | Buy | $8K | 2026-05-19 |
Companies that share insiders with RCEL, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| David D. O'Toole | CFO | Buy | $9K | 2026-03-11 |
| David D. O'Toole | CFO | Buy | $12K | 2026-02-19 |
| Robert McNamara | Director | Buy | $45K | 2025-08-28 |
| David D. O'Toole | CFO | Buy | $9K | 2025-08-26 |
| Robert McNamara | Director | Buy | $50K | 2025-08-19 |
| David D. O'Toole | CFO | Buy | $10K | 2025-08-12 |
| Robert McNamara | Director | Buy | $183K | 2025-03-06 |
| David D. O'Toole | CFO | Buy | $10K | 2025-02-20 |
| Robert McNamara | Director | Buy | $101K | 2025-02-20 |